Status:
COMPLETED
Drug-coated Balloon in de Novo Chronic Total Occlusions
Lead Sponsor:
National Institute of Cardiology, Warsaw, Poland
Conditions:
Coronary Artery Disease
Total Occlusion of Coronary Artery
Eligibility:
All Genders
18+ years
Brief Summary
The CTO-DENOVO study is a multicenter registry of consecutive patients with de novo coronary chronic total occlusions (CTO) undergoing successful CTO recanalization with the use of drug-coated balloon...
Eligibility Criteria
Inclusion
- de novo coronary CTO undergoing successful recanalization with the use of DCB-only strategy at the occlusion site
Exclusion
- de novo coronary CTO undergoing successful recanalization with the use of DES at the occlusion site
- in-stent CTO
Key Trial Info
Start Date :
December 15 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
309 Patients enrolled
Trial Details
Trial ID
NCT05977842
Start Date
December 15 2012
End Date
January 1 2025
Last Update
January 2 2026
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Graz University Heart Center
Graz, Austria
2
Klinik Ottakring
Vienna, Austria
3
Jolimont Hospital
Uccle, Belgium
4
Županijska bolnica Čakovec
Čakovec, Croatia